DNLI Key Financial Ratios - Denali Therapeutics Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	8.37	—	-44.17%	-61.24%
2026-03-31	9.28	—	-40.13%	-54.86%
2025-12-31	9.16	—	-44.77%	-50.56%
2025-09-30	9.79	—	-47.25%	-53.85%
2025-06-30	10.27	—	-41.08%	-46.64%
2025-03-31	9.56	—	-35.71%	-40.43%
2024-12-31	8.46	—	-30.77%	-34.38%
2024-09-30	9.98	—	-29.40%	-32.42%
2024-06-30	12.46	—	-27.93%	-30.26%
2024-03-31	11.79	—	-8.68%	-9.43%
2023-12-31	13.65	—	-12.59%	-14.09%
2023-09-30	16.06	—	-10.06%	-11.13%
2023-06-30	17.65	—	-9.83%	-10.82%
2023-03-31	3.39	—	-26.29%	-38.33%
2022-12-31	3.77	—	-22.32%	-31.27%
2022-09-30	3.16	—	-24.65%	-37.29%
2022-06-30	3.2	—	-21.96%	-32.09%
2022-03-31	2.9	—	-21.63%	-31.13%
2021-12-31	2.37	—	-20.69%	-30.20%
2021-09-30	19.46	—	2.04%	2.92%
2021-06-30	26.1	—	3.70%	5.21%
2021-03-31	26.22	—	3.74%	5.23%
2020-12-31	20.86	—	4.43%	6.18%
2020-09-30	9.21	—	-21.28%	-25.81%
2020-06-30	9.57	—	-33.34%	-42.97%
2020-03-31	12.7	—	-30.95%	-39.50%
2019-12-31	9.48	—	-35.72%	-50.04%
2019-09-30	10.59	—	-10.95%	-15.07%
2019-06-30	10.66	—	-8.65%	-11.61%
2019-03-31	11.55	—	-7.62%	-9.98%
2018-12-31	14.67	—	-5.47%	-6.63%
2018-09-30	12.13	—	-25.10%	-29.63%
2018-06-30	12.17	—	-21.52%	-25.12%
2018-03-31	21.99	—	-14.75%	-16.80%
2017-12-31	28.92	—	-18.12%	-18.93%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	9.16	—	-44.77%	-50.56%
2024-12-31	8.46	—	-30.77%	-34.38%
2023-12-31	13.65	—	-12.59%	-14.09%
2022-12-31	3.77	—	-22.32%	-31.27%
2021-12-31	2.37	—	-20.69%	-30.20%
2020-12-31	20.86	—	4.43%	6.18%
2019-12-31	9.48	—	-35.72%	-50.04%
2018-12-31	14.67	—	-5.47%	-6.63%
2017-12-31	28.92	—	-18.12%	-18.93%
2016-12-31	—	—	—	92.03%